Dow Up 0.45% Nasdaq Up 0.06%

Agenus Inc. (AGEN)

-NasdaqCM
3.11 Down 0.08(2.51%) 2:07PM EDT - Nasdaq Real Time Price
Prev Close:3.19
Open:3.17
Bid:3.14 x 1000
Ask:3.15 x 500
1y Target Est:5.75
Beta:2.23
Next Earnings Date:N/A
Day's Range:3.08 - 3.20
52wk Range:2.27 - 5.27
Volume:281,392
Avg Vol (3m):906,833
Market Cap:194.93M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 2.51%194.93M
ABPI 0.00%224.39K
DNDNUp 0.74%211.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback